Stockreport

Intersect ENT Announces Publication of a Pooled Analysis of the SINUVA Sinus Implant for Nasal Polyps

Intersect ENT, Inc.  (XENT) 
Last intersect ent, inc. earnings: 2/24 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intersectent.com/investor-relations
PDF Pooled analysis of the RESOLVE and RESOLVE II Studies Provides Level 1a Clinical Evidence MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT® [Read more]